GlassScriptPhysician profile
Gretchen A Lawrence
NPI 1386797090
$12,098.83
in general payments reported to CMS, 2019-2025
33 companies · $587 in 2025
The $587 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,069 · 2020: $2,023 · 2021: $1,022 · 2022: $2,066 · 2023: $1,028 · 2024: $1,303 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,918.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $3,881.02 | 2019-2024 | |
| Treace Medical Concepts, INC. | $1,615.01 | 2020-2025 | |
| Arthrosurface Incorporated | $955.07 | 2019-2020 | |
| Arthrex, INC. | $850.00 | 2019-2020 | |
| Convatec INC. | $831.35 | 2023-2025 | |
| Wright Medical Technology, INC. | $583.78 | 2019 | |
| Paratek Pharmaceuticals, INC. | $500.50 | 2022-2025 | Nuzyra |
| Amgen INC. | $385.85 | 2024-2025 | Krystexxa |
| Melinta Therapeutics, LLC | $301.55 | 2019-2023 | Kimyrsa, Orbactiv, Vabomere |
| Horizon Therapeutics Plc | $279.01 | 2019-2023 | Krystexxa |
| Averitas Pharma INC. | $245.02 | 2023-2025 | Qutenza |
| Bioventus LLC | $212.22 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $207.78 | 2019-2025 | Collagenase Santyl |
| Triad Life Sciences INC. | $191.30 | 2022 | |
| Stryker Corporation | $171.17 | 2024 | Hoffmann, Citrefix |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $122.12 | 2020-2025 | Puraply Wound Matrix, Apligraf |
| Sebela Pharmaceuticals INC. | $95.94 | 2019-2023 | Naftin |
| Ani Pharmaceuticals, INC. | $72.27 | 2025 | Purified Cortrophin Gel |
| Kowa Pharmaceuticals America, INC. | $71.13 | 2022-2023 | Seglentis |
| Next Science LLC | $66.14 | 2023 | Xperience, Blastx, Surgx |
| Nabriva Therapeutics, Plc | $65.13 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $57.20 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.04 | 2022-2025 | Jublia |
| Depuy Synthes Sales INC. | $42.50 | 2022 | |
| Kerecis Limited | $40.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Tactile Systems Technology INC | $39.66 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Polarityte, INC. | $38.88 | 2020 | |
| Nevro Corp. | $34.08 | 2022 | |
| Medtronic, INC. | $21.85 | 2022 | |
| Medline Industries LP | $21.45 | 2019 | |
| Hikma Pharmaceuticals USA | $19.87 | 2022 | |
| Solventum Corporation | $14.12 | 2024 | Activ.A.C., Snap, Promogran Prisma |
| Pfizer INC. | $12.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.